Jennifer Balliet is VP at NEOGENOMICS INC (NEO). They have made 10 open-market trades across 1 company since 2017, most recently 2021-12-30.
CIK 0001640500
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NEO | 48,615 | $810K |
Shares reported on the most recent Form 4, priced at the 2021-12-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NEO | SELL | 2020-12-11 | 2020-12-11 | $49.99 | $750K | +8.9% | +4.8% | -5.3% |
| NEO | SELL | 2020-08-03 | 2020-08-04 | $39.25 | $510K | -0.2% | -5.2% | -2.0% |
| NEO | SELL | 2019-11-15 | 2019-11-18 | $23.45 | $320K | +5.6% | +16.1% | +39.4% |
| NEO | SELL | 2019-05-03 | 2019-05-06 | $22.74 | $1.4M | +0.3% | -4.2% | +0.5% |
| NEO | SELL | 2019-02-28 | 2019-03-04 | $19.42 | $854K | +3.0% | +8.7% | +13.5% |
| NEO | SELL | 2018-11-09 | 2018-11-13 | $16.84 | $1.6M | -0.1% | -18.6% | +1.3% |
| NEO | SELL | 2018-05-29 | 2018-05-31 | $11.66 | $758K | +11.6% | +18.2% | +18.8% |
| NEO | SELL | 2018-05-15 | 2018-05-17 | $11.24 | $146K | +3.4% | +14.9% | +10.8% |
| NEO | SELL | 2017-06-22 | 2017-06-26 | $8.49 | $182K | +0.8% | +6.8% | +28.0% |
| NEO | SELL | 2017-05-26 | 2017-05-30 | $7.50 | $25K | +11.9% | +22.2% | +26.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.